| CDA | Canadian Dental Association; Certified Dental Assistant; chenodeoxycholic acid; ciliary dyskinesia a... |
|---|---|
| CPT | carnitine palmityl transferase; carotid pulse tracing; chest physiotherapy; child protection team; c... |
| PCD | pacer-cardioverter-defibrillator; papillary collecting duct; paraneoplastic cerebellar degeneration;... |
| SPCD | syndrome of primary ciliary dyskinesia |
| DF | decapacitation factor; decontamination factor; deferoxamine; deficiency factor; defined flora [anima... |
| short posterior ciliary artery | <anatomy, artery> One of approximately seven branches of the ophthalmic artery which pass around the optic nerve to supply the eyeball. Dividing into some 15-20 branches, they penetrate the sclera adjacent to the optic nerve, supplying the choroid and ciliary processes. Anastomoses: with central retinal artery and long and anterior ciliary arteries (at the ora serrata). Synonym: arteria ciliaris posterior brevis. (05 Mar 2000) |
|---|---|
| short root of ciliary ganglion | A branch of the oculomotor nerve supplying parasympathetic preganglionic nerve fibres to the ciliary ganglion. Synonym: radix parasympathica ganglii ciliaris, radix oculomotoria ganglii ciliaris, motor root of ciliary ganglion, oculomotor root of ciliary ganglion, radix brevis ganglii ciliaris, short root of ciliary ganglion. (05 Mar 2000) |
| sympathetic root of ciliary ganglion | Postganglionic fibres,having cell bodies in the superior cervical ganglion, branching from the carotid plexus passing through the ciliary ganglion without synapse to reach the eyeball. Synonym: radix sympathica ganglii ciliaris. (05 Mar 2000) |
| oculomotor root of ciliary ganglion | A branch of the oculomotor nerve supplying parasympathetic preganglionic nerve fibres to the ciliary ganglion. Synonym: radix parasympathica ganglii ciliaris, radix oculomotoria ganglii ciliaris, motor root of ciliary ganglion, oculomotor root of ciliary ganglion, radix brevis ganglii ciliaris, short root of ciliary ganglion. (05 Mar 2000) |
| embryonal tumour of ciliary body | <tumour> An epitheliomatous tumour of the nonpigmented layer of the ciliary epithelium. Synonym: embryonal tumour of ciliary body. (05 Mar 2000) |
| long ciliary nerve | <anatomy, nerve> One of two or three branches of the nasociliary nerve, which by-pass the ciliary ganglion, supplying post-synaptic sympathetic fibres for the dilator pupillae muscle and sensory fibres for the ciliary muscles, iris, and cornea. Synonym: nervus ciliaris longus. (05 Mar 2000) |
| long root of ciliary ganglion | Sensory fibres passing from the eyeball through the ciliary ganglion to their cell bodies in the trigeminal ganglion via the nasociliary nerve. Synonym: radix sensoria ganglii ciliaris, ramus communicans nervi nasociliaris cum ganglio ciliari, radix nasociliaris, long root of ciliary ganglion, nasociliary root, radix longa ganglii ciliaris. (05 Mar 2000) |
| acetylcholine receptor antibodies | <neurology, investigation> A test used to measure the amount of antibodies to acetylcholine receptors on nerve endings. This is a diagnostic test for myasthenia gravis. A normal value is no antibodies in the bloodstream. Acetylcholine receptor (AChR) binding autoantibodies (i.e. Antibodies reactive with several epitopes other than the binding site for acetylcholine or alpha-bungarotoxin) are present in approximately 88% of patients with generalised myasthenia gravis, 70% of ocular myasthenia and in approximately 80% of myasthenia gravis in remission. Although serum concentrations of AChR binding autoantibodies do not in general correlate well with severity of weakness, there is typical decrease in concentration as weakness improves with immunosuppressive therapy. AChR blocking autoantibodies (i.e., antibodies reactive with the AChR binding site) are present in about 50% of patients with myasthenia gravis, 30% with ocular myasthenia gravis and 20% of myasthenia gravis in remission, AChR blocking autoantibodies are the only AChR autoantibodies present in about 1% of myasthenia gravis. AChR modulating autoantibodies (i.e., autoantibodies which cross-link AChRs and cause their removal from muscle membrane surfaces) are present in more than 90% of myasthenia gravis and occasionally are the only AchR autoantibodies detectable in mild, recent onset or ocular-restricted myasthenia gravis. Results for AChR modulating autoantibodies can be transiently false-positive due to curare-like drugs used during general anesthesia. AChR autoantibodies of one or more types are found in at least 80% of ocular myasthenia gravis. Although generally absent in neurological conditions other than myasthenia gravis(and consequently unlikely to cause confusion in neurodiagnosis), false-positive results for AChR autoantibodies occasionally occur in primary biliary cirrhosis, tardive dyskinesia, autoimmune thyroiditis, the elderly, amyotrophic lateral sclerosis patients treated with cobra venom and patients with thymoma in the absence of myasthenia gravis. Approximately 1% of patients with rheumatoid arthritis treated with D-penicillamine develop AChR autoantibodies and myasthenia gravis, both of which disappear when the drug is discontinued. Babies born to ~10% of myasthenia gravis mothers have a transient neonatal form of myasthenia gravis that responds well to anticholinesterase therapy and usually remits within 1 month as maternal IgG disappears. (29 Dec 1997) |
| amino acid receptor | <biochemistry> Ligand gated ion channels with specific receptors for amino acid transmitters. An extended protein superfamily that also includes subunits of the nicotinic acetylcholine receptor. (18 Nov 1997) |
| AMPA receptor | <cell biology> Glutamate operated ion channel. See: excitatory amino acid receptor channels. (05 Feb 1998) |
| ANP receptor | <molecular biology> Family of 3 receptors for atrial natriuretic peptide. ANP A and ANP B have intracellular guanylate cyclase and protein kinase like domains. ANP C, shares the extracellular ligand binding and transmembrane domains, but lacks the functional intracellular domains and is not thought to be involved in signal transduction. (18 Nov 1997) |
| asialoglycoprotein receptor | A surface receptor found in hepatocytes that binds galactose-terminal glycoproteins; thus, this receptor removes those proteins from circulation and they are in turn acted upon by hepatocyte lysosomes. (05 Mar 2000) |
| auditory receptor cells | Columnar cell's in the epithelium of the organ of Corti, having hairs (stereocilia) on their apical ends. See: Corti's cells. (05 Mar 2000) |
| beta-adrenergic receptor blocking agent | A class of drugs that compete with beta-adrenergic agonists for available receptor sites; some compete for both b1 and b2 receptors (e.g., propranolol) while others are primarily either b1 (e.g., metoprolol) or b2 blockers; used in the treatment of a variety of cardiovascular diseases where beta-adrenergic blockade is desirable. Synonym: beta-adrenergic receptor blocking agent, beta-adrenoreceptor antagonist, beta-blocker. (05 Mar 2000) |
| beta-adrenergic receptor kinase | <enzyme> Cyclic-AMP protein kinase which specifically phosphorylates the agonist-occupied form of beta-adrenergic receptor Registry number: EC 2.7.1.- Synonym: beta-ar kinase, beta-adrenergic receptor kinase 1, g-protein-coupled receptor kinase 2, grk2 (kinase), beta-adrenergic receptor kinase 2, beta-ar kinase 2 (26 Jun 1999) |